Personal information
Verified email addresses
mtvarela@unifesp.br
Verified email domains
unifesp.br
Brazil
Activities
Employment (2)
2023-10-01
to
present
|
Post-Doctoral Researcher
(Instituto de Química)
Employment
Source:
Marina Themoteo Varela
2022-11-01
to
2023-09-30
|
Post-Doctoral Researcher
(Pharmaceutical Sciences)
Employment
Source:
Marina Themoteo Varela
Education and qualifications (4)
2018-06-01
to
2022-09-30
|
PhD
(Medicine)
Education
Source:
Marina Themoteo Varela
2020-03-01
to
2021-02-28
|
PhD Student
(Biological Chemistry and Drug Discovery)
Qualification
Source:
Marina Themoteo Varela
2016-04-01
to
2018-03-28
|
Master Degree
(Pharmaceutical Sciences)
Education
Source:
Marina Themoteo Varela
2011-03-28
to
2016-03-10
|
Bachelor
(Pharmaceutical Sciences)
Education
Source:
Marina Themoteo Varela
Professional activities (1)
2018-12-12
|
Menção Honrosa - Jovem Pesquisador
Distinction
Source:
Marina Themoteo Varela
Works (19)
ACS Omega
2023-11-21
|
Journal article
Contributors:
Marina T. Varela;
Erica V. de Castro Levatti;
Tempone AG;
João Paulo dos Santos Fernandes
Source:
Marina Themoteo Varela
Saudi Pharmaceutical Journal
2023-07
|
Journal article
Contributors:
Marina T. Varela;
Maiara Romanelli;
Maiara Amaral;
Andre G. Tempone;
João Paulo S. Fernandes
Source:
check_circle
Crossref
Life
2023-02-28
|
Journal article
Contributors:
Maiara Amaral;
Marina T. Varela;
Ravi Kant;
Myron Christodoulides;
João Paulo S. Fernandes;
Andre G. Tempone
Source:
check_circle
Crossref
grade
Preferred source
(of
2)
Biomedicines
2023-01-12
|
Journal article
Contributors:
Marina Themoteo Varela
Source:
Marina Themoteo Varela
grade
Preferred source
(of
3)
European Journal of Pharmaceutical Sciences
2022-04
|
Journal article
Source:
Marina Themoteo Varela
Chemical Biology & Drug Design
2022-03
|
Journal article
Source:
Marina Themoteo Varela
Bioorganic and Medicinal Chemistry
2021
|
Journal article
EID:
2-s2.0-85097780585
Contributors:
Corrêa, M.F.;
Balico-Silva, A.L.;
Kiss, D.J.;
Fernandes, G.A.B.;
Maraschin, J.C.;
Parreiras-e-Silva, L.T.;
Varela, M.T.;
Simões, S.C.;
Bouvier, M.;
Keserű, G.M.
et al.
Source:
Marina Themoteo Varela
via
Scopus - Elsevier
Folia Microbiologica
2020
|
Journal article
EID:
2-s2.0-85089731569
Contributors:
Waller, S.B.;
Cleff, M.B.;
Ripoll, M.K.;
Meireles, M.C.A.;
Varela, M.T.;
Fernandes, J.P.S.
Source:
Marina Themoteo Varela
via
Scopus - Elsevier
Bioorganic Chemistry
2020
|
Journal article
EID:
2-s2.0-85088954941
Contributors:
Varela, M.T.;
Ferrarini, M.;
Mercaldi, V.G.;
Sufi, B.D.S.;
Padovani, G.;
Nazato, L.I.S.;
Fernandes, J.P.S.
Source:
Marina Themoteo Varela
via
Scopus - Elsevier
Scientific Reports
2020
|
Journal article
EID:
2-s2.0-85082589194
Contributors:
Morais, T.R.;
Conserva, G.A.A.;
Varela, M.T.;
Costa-Silva, T.A.;
Thevenard, F.;
Ponci, V.;
Fortuna, A.;
Falcão, A.C.;
Tempone, A.G.;
Fernandes, J.P.S.
et al.
Source:
Marina Themoteo Varela
via
Scopus - Elsevier
Journal of Chemical Sciences
2020
|
Journal article
EID:
2-s2.0-85076786444
Contributors:
Corrêa, M.F.;
Reiner, D.;
Fernandes, G.A.B.;
Varela, M.T.;
Aranha, C.M.S.Q.;
Stark, H.;
Fernandes, J.P.S.
Source:
Marina Themoteo Varela
via
Scopus - Elsevier
European Journal of Pharmaceutical Sciences
2020-10
|
Journal article
Source:
Marina Themoteo Varela
grade
Preferred source
(of
4)
Bioorganic Chemistry
2019-08
|
Journal article
Source:
Marina Themoteo Varela
grade
Preferred source
(of
2)
Source:
Marina Themoteo Varela
grade
Preferred source
(of
2)
European Journal of Pharmaceutical Sciences
2018-09
|
Journal article
Source:
Marina Themoteo Varela
grade
Preferred source
(of
2)
Current Medicinal Chemistry
2018-05-01
|
Journal article
Source:
Marina Themoteo Varela
grade
Preferred source
(of
2)
Chemical Biology & Drug Design
2017-11
|
Journal article
Source:
Marina Themoteo Varela
grade
Preferred source
(of
2)
Chemical Biology & Drug Design
2017-08
|
Journal article
Source:
Marina Themoteo Varela
grade
Preferred source
(of
2)
Bioorganic & Medicinal Chemistry Letters
2016-02
|
Journal article
Source:
Marina Themoteo Varela
grade
Preferred source
(of
2)